Quantitative mass spectrometry plays an ever larger role in peptide-related research, from proteomics studies to the characterisation of synthetic research peptides. But an LC-MS/MS signal is not in itself a reliable measure of concentration: ionisation efficiency differs per run, per instrument and per matrix. Stable isotope labelled (SIL) peptides were developed to solve that problem. This article describes what SIL peptides are, why they are used in quantitative workflows, and what is watched for in their synthesis and quality control.

What are stable isotope labelled peptides?

A SIL peptide has the same amino acid sequence as the peptide of interest, but at one or more positions atoms have been replaced by their heavy, stable isotopes: ¹³C instead of ¹²C, ¹⁵N instead of ¹⁴N, or deuterium (²H) instead of hydrogen. Chemically the labelled peptide behaves almost identically to the unlabelled variant: the same retention time on reversed-phase HPLC, comparable ionisation efficiency in the source of the mass spectrometer. The only difference is the mass, which increases by a fixed, predictable number of daltons. In the MS detector the labelled peptide therefore appears as a separate signal, shifted relative to the endogenous or synthetic peptide, while chromatographically it all but coincides with it.

Why an internal standard is needed

In quantitative LC-MS/MS, signal intensity depends not only on the quantity of analyte, but also on matrix effects such as ion suppression, variation in sample preparation and instrument drift between measurements. An external calibration point does not correct for that fully, because it does not take account of what happens in the specific sample. A SIL peptide added to the sample before extraction undergoes exactly the same sample preparation, chromatographic separation and ionisation as the peptide being quantified. By calculating the signal ratio between the endogenous peptide and the known quantity of internal standard, many of these variables cancel out. This principle — comparable to the AQUA method (Absolute QUAntification) described in the proteomics literature — makes reproducible, absolute quantification possible in complex matrices.

Synthesis strategy: where is the label placed?

SIL peptides are usually built via solid-phase peptide synthesis (Fmoc-SPPS), with a labelled Fmoc amino acid incorporated at one or more specific positions in place of the standard building block. The choice of position and mass shift is no accident:

• Mass shift: a difference of at least 4-5 Da relative to the unlabelled peptide is maintained, so that the isotope pattern of the standard does not overlap the natural isotope envelope of the endogenous peptide.
• Position in the sequence: labelling is done preferably on amino acids that are stable during synthesis and storage, and not at positions prone to chemical modification (such as deamidation or oxidation), to avoid unwanted mass shifts during the research.
• Type of label: ¹³C and ¹⁵N labelling is generally preferred over deuterium labelling, because deuterium at some positions can exchange with the solvent (back-exchange) and so shift the mass of the standard unpredictably.

Quality control: chemical and isotopic purity

With SIL peptides it is not only chemical purity that counts — established via RP-HPLC and mass spectrometry, as with any research peptide — but also the degree of isotopic enrichment. A batch of labelled building blocks never contains exactly 100% of the heavy isotope; a small percentage of the molecules contains the light, natural variant. This isotopic purity is expressed as a percentage and is a separate specification on the certificate of analysis, alongside the usual chemical purity and net peptide content. For quantitative research measuring low concentrations, a high isotopic enrichment (usually >98%) is relevant, because lower enrichment contributes to background signal at the position of the endogenous peptide.

Application in published research

In the proteomics and bioanalytical literature, SIL peptides are described as internal standards for quantifying target proteins and peptides in complex biological matrices via multiple-reaction monitoring (MRM) or parallel-reaction monitoring (PRM) on triple quadrupole and Orbitrap instruments. Published method validations generally report the linearity, precision and accuracy of such assays across a defined concentration range. Such publications describe the application of SIL peptides within a research method; they say nothing about personal use of the peptides in question.

Products and information of Dutch Peptide Labs are intended solely for laboratory and research purposes. They are not intended for human or animal consumption, diagnostic use or therapeutic application.